Axios (June 17, 2022) Another Alzheimer’s drug disappoints
Hopes for new Alzheimer’s drugs took another disappointing turn Thursday, when Roche said an antibody therapy in a long-running trial didn’t help people with a rare genetic condition that causes early-onset Alzheimer’s.
One Green Planet (June 17, 2022) FDA Modernization Act: Landmark Animal Testing Bill Passes in the House That Will Save Animals, Reduce Drug Prices and Produce Safer Treatments
In what is a landmark decision for both humans and animals, the U.S. House of Representatives passed the FDA Modernization Act last week, which would stop the mandate for animal testing in the drug development process and allow for more modern and effective methods to take their place where they are available.